{
    "Trade/Device Name(s)": [
        "QUANTA Flash\u00ae SS-B",
        "QUANTA Flash\u00ae SS-B Calibrators",
        "QUANTA Flash\u00ae SS-B Controls"
    ],
    "Submitter Information": "INOVA Diagnostics, Inc.",
    "510(k) Number": "K141210",
    "Predicate Device Reference 510(k) Number(s)": [
        "K922832"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LLL",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "December 29, 2014",
    "Summary Letter Received Date": "December 30, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.5100",
        "21CFR862.1150",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Antinuclear antibody immunological test system",
        "Calibrator",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "IgG anti-SS-B autoantibodies"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BIO-FLASH\u00ae instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay"
    ],
    "Methodologies": [
        "Solid phase immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for QUANTA Flash SS-B chemiluminescent immunoassay, calibrators, and controls for detection of IgG anti-SS-B autoantibodies in human serum",
    "Indications for Use Summary": "Semi-quantitative determination of IgG anti-SS-B autoantibodies in human serum as an aid in the diagnosis of Sj\u00f6gren\u2019s Syndrome and Systemic Lupus Erythematosus",
    "fda_folder": "Immunology"
}